ODU Digital Commons
metadata only
Mepolizumab Improves Outcomes in Patients with CRSwNP With One or More Prior Nasal Polyp Surgeries
BACKGROUND: Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) often undergo multiple nasal surgeries. The Phase III SYNAPSE study (GSK ID:205687; NCT0308579) demonstrated that mepolizumab reduces the need for repeat surgery. We explored whether outcomes differed based on the number of
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Assessment of Rituximab's Immunomodulatory Synovial Effects (The ARISE Study)#979589
- Corticosteroid Therapy for Persistent Synovitis in Acute Septic Arthritis on Native Joint#1103274
- Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML#1115298
- Utility of PCD Diagnostics to Improve Clinical Care#1163915
- REMission INDuction in Very Early Rheumatoid Arthritis#1112694
Record · ID 1134997
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive